Objective: This multicenter, prospective, nonrandomized trial was undertaken to evaluate the first-in-human experience with the INCRAFT endograft (Cordis Corporation, Bridgewater, NJ), an ultralow-profile trimodular bifurcate device for the repair of abdominal aortic aneurysms.
Objectives: This study sought to evaluate the outcomes of drug-eluting stent treatment for femoropopliteal in-stent restenosis (ISR).
Aims: Although acute venous thrombo-embolism (VTE) often afflicts patients with advanced age, the predictors of in-hospital mortality for elderly VTE patients are unknown.
Objectives: This study aimed to appraise 2-year outcomes after percutaneous treatment of femoropopliteal artery disease with paclitaxel-eluting balloons.
Rationale and Objectives: The aims of this study were to assess the prevalence of noncalcified coronary plaques in asymptomatic patients and to investigate the risk factors.
Amplatzer septal occluder devices (AGA Medical Corporation, Plymouth, MN) have been used in the treatment of saccular and aortic false aneurysms.1,2 We have reservations about the long-term reliability of this approach.
Patients presenting with femoropopliteal (FP) disease often require revascularization for lifestyle-limiting claudication medical therapy that failed, or for critical limb ischemia. Percutaneous revascularization for FP disease has been fraught with challenges since the initial description of percutaneous transluminal balloon angioplasty (PTA) of the FP artery. Due to high rates of arterial dissection and restenosis after PTA, randomized comparisons of self-expanding stents and PTA for FP disease have been performed and have demonstrated the superiority of stenting ((1),2). Nevertheless, restenosis rates with self-expanding nitinol stents are 19% to 37% at 1-year follow-up, and options for the treatment of FP restenosis are limited ((1),2). Additionally, because this vessel undergoes significant torsion, extension, and flexion during daily activity, FP stent fractures have been reported that are associated with restenosis (3) and potential distal embolization of stent fragments. Self-expanding stent grafts covered with expanded polytetrafluoroethylene (ePTFE) (Viabahn, Gore Medical, Newark, Delaware) lead to comparable outcomes as surgical FP bypass using prosthetic conduits, (4) but can result in occlusion of collaterals and are not an appropriate initial treatment option for most patients with FP disease. Clinical outcomes from registries evaluating the use of extraction, rotational, and laser atherectomy for the treatment of FP disease have been encouraging but have not been compared in an adequately powered randomized clinical trial against PTA.
Objectives: This study evaluated the use of a paclitaxel-eluting balloon (PEB) for treatment of femoropopliteal arterial disease.
The main limitation of endovascular treatment modalities in the femoropopliteal tract is the high rate of recurrent lesions necessitating repeat interventions. Although 1-year patency rates of plain balloon angioplasty might be as low as 30% to 40% (1), improved results have been reported with a primary stenting approach. Nevertheless, depending on the lesion length, in-stent-restenosis rates at 1 year are still in the range of 20% to 40% (2- 5). Particularly in longer lesions, the occurrence of stent fractures seems to contribute to the development of in-stent-restenosis and has the potential to further complicate subsequent endovascular procedures (6).
Objectives The purpose of this study was to examine the role of heparanase in controlling thrombosis following vascular injury or endovascular stenting.
Objectives: We examined the efficacy and durability of a new interwoven self-expanding nitinol stent system in the treatment of complex popliteal artery lesions in unselected patients.
Objectives: This study sought to evaluate the early and long-term effect of thoracic endovascular aortic repair (TEVAR) on type-B acute aortic dissection (AAD).
Objectives: The goal of this study was to prospectively assess blood pressure (BP) and echocardiographic parameters to delineate the incidence and nature of the hypertension burden in this cohort.
Aims The time course of atherosclerosis burden in distinct vascular territories remains poorly understood. We longitudinally evaluated the natural history of atherosclerotic progression in two different arterial territories using high spatial resolution magnetic resonance imaging (HR-MRI), a powerful, safe, and non-invasive tool.
Background—Claudication is a common and disabling symptom of peripheral artery disease that can be treated with medication, supervised exercise (SE), or stent revascularization (ST).
Cookies Sociales
Son esos botones que permiten compartir el contenido del sitio web en sus redes sociales (Facebook, Twitter y Linkedin, previo tu consentimiento y login) a través de sistemas totalmente gestionados por dichas redes sociales, así como los recursos (pej. videos) y material que se encuentra en nuestra web, y que de igual manera se presta y gestiona completamente por un tercero.
Si no acepta estas cookies, no podrá compartir nuestro contenido a través de los botones, y en su caso, no podrás visualizar el contenido de terceros que hayamos incrustado en el sitio.
No las utilizamos